SARS-CoV-2 Spike S1 Protein Antibody (1035226) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB105805JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG2A Clone # 1035226
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293-derived SARS-CoV-2 Spike S1 Subunit
Accession # YP_009724390.1
Accession # YP_009724390.1
Specificity
Detects SARS-CoV-2 Spike S1 and SARS-CoV-2 B.1.1.529 S RBD (Omicron Variant) in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for SARS-CoV-2 Spike S1 Protein Antibody (1035226) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Spike S1 Subunit
Long Name
Spike Protein, S1 Subunit
Alternate Names
SARS-CoV-2
Additional Spike S1 Subunit Products
Product Specific Notices for SARS-CoV-2 Spike S1 Protein Antibody (1035226) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...